$2.38 Billion is the total value of Deep Track Capital, LP's 60 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 46.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IMVT | Sell | IMMUNOVANT INC | $172,352,500 | +213.3% | 9,710,000 | -1.5% | 7.24% | +187.1% |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $85,491,000 | +3.5% | 700,000 | -12.5% | 3.59% | -5.1% |
| BCYC | Sell | BICYCLE THERAPEUTICS PLCsponsored ads | $83,443,732 | +23.7% | 2,819,045 | -2.8% | 3.50% | +13.4% |
| FDMT | Sell | 4D MOLECULAR THERAPEUTICS IN | $59,009,771 | +129.6% | 2,656,901 | -16.9% | 2.48% | +110.5% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $56,900,000 | -37.1% | 500,000 | -65.8% | 2.39% | -42.4% |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $51,735,408 | +28.0% | 1,771,154 | -10.1% | 2.17% | +17.3% |
| RPTX | Sell | REPARE THERAPEUTICS INC | $40,123,084 | +5.8% | 2,727,606 | -12.8% | 1.68% | -3.0% |
| DYN | Sell | DYNE THERAPEUTICS INC | $31,109,878 | -23.1% | 2,684,200 | -15.7% | 1.31% | -29.5% |
| ASND | Sell | ASCENDIS PHARMA A/Scall | $30,447,009 | -70.5% | 249,300 | -75.1% | 1.28% | -73.0% |
| Sell | VIGIL NEUROSCIENCE INC | $26,302,175 | +22.3% | 2,104,174 | -11.0% | 1.10% | +12.1% | |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $24,920,000 | -34.0% | 4,000,000 | -29.0% | 1.05% | -39.5% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $19,642,402 | -68.6% | 189,800 | -74.3% | 0.82% | -71.2% |
| CRNX | Sell | CRINETICS PHARMACEUTICALS IN | $19,193,571 | -7.2% | 1,048,829 | -0.4% | 0.81% | -14.9% |
| HRTX | Sell | HERON THERAPEUTICS INC | $16,242,440 | -55.0% | 6,496,976 | -24.0% | 0.68% | -58.7% |
| NUVB | Sell | NUVATION BIO INC | $15,784,681 | -24.4% | 8,221,188 | -11.8% | 0.66% | -30.7% |
| NKTX | Sell | NKARTA INC | $8,111,658 | -78.1% | 1,354,200 | -51.9% | 0.34% | -79.9% |
| FULC | Sell | FULCRUM THERAPEUTICS INC | $5,595,459 | -23.2% | 768,607 | -14.7% | 0.24% | -29.6% |
| IPSC | Sell | CENTURY THERAPEUTICS INC | $3,569,685 | -61.0% | 695,845 | -24.7% | 0.15% | -64.2% |
| ASMB | Sell | ASSEMBLY BIOSCIENCES INC | $2,383,468 | -51.6% | 1,833,437 | -38.9% | 0.10% | -55.6% |
| Sell | THIRD HARMONIC BIO INC | $1,915,960 | -92.0% | 445,572 | -64.9% | 0.08% | -92.7% | |
| AUPH | Sell | AURINIA PHARMACEUTICALS INC | $1,400,708 | -96.7% | 324,238 | -94.3% | 0.06% | -97.0% |
| MGTA | Sell | MAGENTA THERAPEUTICS INC | $1,185,000 | -84.3% | 3,000,000 | -44.0% | 0.05% | -85.5% |
| HOOK | Sell | HOOKIPA PHARMA INC | $1,004,699 | -85.1% | 1,240,369 | -75.4% | 0.04% | -86.4% |
| GRTS | Exit | GRITSTONE BIO INC | $0 | – | -45,500 | -100.0% | -0.01% | – |
| PASG | Exit | PASSAGE BIO INC | $0 | – | -1,439,062 | -100.0% | -0.08% | – |
| SDGR | Exit | SCHRODINGER INC | $0 | – | -170,000 | -100.0% | -0.19% | – |
| RLMD | Exit | RELMADA THERAPEUTICS INCcall | $0 | – | -117,200 | -100.0% | -0.20% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCput | $0 | – | -316,800 | -100.0% | -0.36% | – |
| TCDA | Exit | TRICIDA INCcall | $0 | – | -772,700 | -100.0% | -0.37% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -360,000 | -100.0% | -0.42% | – |
| KROS | Exit | KEROS THERAPEUTICS INC | $0 | – | -248,500 | -100.0% | -0.43% | – |
| ACET | Exit | ADICET BIO INC | $0 | – | -825,508 | -100.0% | -0.54% | – |
| TCDA | Exit | TRICIDA INC | $0 | – | -1,177,680 | -100.0% | -0.56% | – |
| ARDX | Exit | ARDELYX INC | $0 | – | -14,858,000 | -100.0% | -0.81% | – |
| FMTX | Exit | FORMA THERAPEUTICS HLDGS INC | $0 | – | -966,573 | -100.0% | -0.88% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -326,600 | -100.0% | -1.02% | – |
| KALV | Exit | KALVISTA PHARMACEUTICALS INC | $0 | – | -1,824,000 | -100.0% | -1.21% | – |
| VERV | Exit | VERVE THERAPEUTICS INC | $0 | – | -775,000 | -100.0% | -1.22% | – |
| AKRO | Exit | AKERO THERAPEUTICS INC | $0 | – | -790,926 | -100.0% | -1.23% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -1,311,113 | -100.0% | -1.35% | – |
| ISEE | Exit | IVERIC BIO INCcall | $0 | – | -2,000,000 | -100.0% | -1.64% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -3,186,083 | -100.0% | -1.99% | – |
| NVCR | Exit | NOVOCURE LTD | $0 | – | -1,293,761 | -100.0% | -4.50% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| JAZZ PHARMACEUTICALS PLC | 8 | Q3 2023 | 7.2% |
| TRAVERE THERAPEUTICS INC | 8 | Q3 2023 | 5.7% |
| IMMUNOVANT INC | 8 | Q3 2023 | 7.2% |
| BICYCLE THERAPEUTICS PLC | 8 | Q3 2023 | 5.2% |
| BEAM THERAPEUTICS INC | 8 | Q3 2023 | 3.9% |
| 4D MOLECULAR THERAPEUTICS IN | 8 | Q3 2023 | 2.9% |
| REPARE THERAPEUTICS INC | 8 | Q3 2023 | 3.1% |
| VIRIDIAN THERAPEUTICS INC | 8 | Q3 2023 | 2.2% |
| DYNE THERAPEUTICS INC | 8 | Q3 2023 | 2.2% |
| SILENCE THERAPEUTICS PLC | 8 | Q3 2023 | 1.6% |
View Deep Track Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Orchard Therapeutics plc | March 20, 2023 | 19,125,150 | 10.0% |
| ARDELYX, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2023 | 1,833,437 | 3.8% |
| Aurinia Pharmaceuticals Inc. | February 14, 2023 | 324,238 | 0.2% |
| CHINOOK THERAPEUTICS, INC. | February 14, 2023 | 3,000,000 | 4.7% |
| Forma Therapeutics Holdings, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Global Blood Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| HOOKIPA Pharma Inc. | February 14, 2023 | 1,240,369 | 2.4% |
| KalVista Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Keros Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View Deep Track Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-26 |
| SC 13G | 2024-04-26 |
| SC 13G/A | 2024-04-22 |
| SC 13G | 2024-04-12 |
| SC 13G | 2024-04-05 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-15 |
| 3 | 2024-03-14 |
View Deep Track Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.